Author

J.M. Extra

Observed names: J-M Extra, J-M. Extra

Observed institutions: Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Assistance Publique – Hôpitaux de Paris, Centre de Recherche en Cancérologie de Marseille, Hôpital Saint-Louis, Institut Paoli-Calmettes, Institut Jean Godinot, Université Paris Diderot, Institut Curie

OpenAlex ID: A5110054004

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

2014 · S Giacchetti, R Porcher, et al. · British Journal of Cancer · 33

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

2016 · L Boudin, A Gonçalves, et al. · Bone Marrow Transplantation · 17

Abstract OT2-3-05: AVASTEM: a phase II randomized trial evaluating anti-cancer stem cell activity of pre-operative bevacizumab and chemotherapy in breast cancer

2012 · A Gonçalves, J-Y Pierga, et al. · Cancer Research · 4

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

2006 · A Gonçalves, R Delva, et al. · Bone Marrow Transplantation · 4

Erratum: Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

2017 · L Boudin, A Gonçalves, et al. · Bone Marrow Transplantation · 3

Final Results From the ATALANTE/ENGOT-ov29 Randomized Phase III Trial of Atezolizumab, Bevacizumab, and Platinum-Based Therapy for Late-Relapsing Recurrent Ovarian Cancer

2026 · Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, et al. · JCO oncology advances. · 2

Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy

2017 · R. Sabatier, A. Meskine, et al. · Annals of Oncology · 1

Abstract P2-10-02: AVASTEM – Stem cells inhibition by bevacizumab in combination with neoadjuvant chemotherapy for locally advanced breast cancers: A prospective proof of concept randomized phase II trial

2019 · R Sabatier, E Charafe-Jauffret, et al. · Cancer Research

Abstract P4-13-23: Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH) and patient-derived tumor xenograft (PDX) for precision medicine in advanced breast cancer: A single-center prospective study

2016 · A Gonçalves, F Bertucci, et al. · Cancer Research

Works count: 9

Citation count: 64

H-index: 4

I10-index: 2